As Initial Coin Offerings (ICOs) begin to gain mainstream acceptance as a mode of fundraising, the German and Swiss financial regulators have recently issued statements detailing their outlook on ICOs.

April 6, 2014 was a red letter day for the Indian pharmaceutical industry as Sun Pharmaceutical Industries Limited ("Sun Pharma") and Ranbaxy Laboratories Limited ("Ranbaxy") announced that they had entered into definitive documents for merger of Ranbaxy with Sun Pharma ("Transaction").

The Reserve Bank of India in continuance with its measures of liberalization of policies governing foreign direct investment in India has, through its circular no. 38 dated September 6, 2013, relaxed the restriction on non-resident investors in terms of acquisition of shares on the floor of stock exchange.

Based on Mondaq users readership, this author is ranked as Very Popular in India for the topics, user groups and industry sectors listed below:

Position

Inhouse Counsel, Lawyer in Company/Government

Corporate/Company Secretary, Compliance Officer

Director, Vice President, Senior Company Executive

Industry

Government

Basic Industries

Securities & Investment

Financial Services & Insurance

* Rankings are based on analysis of the last 12 months of Mondaq readership data across more than 25,000 contributing authors. To be ranked ‘Very Popular’ an author must be in the top 20% of results within the selected criteria.